 | • レポートコード：D005-00922 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、軟部肉腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。軟部肉腫治療の種類別市場規模（化学治療、標的治療、抗血管新生薬、放射線治療）、用途別市場規模（病院、腫瘍学センター、長期ケアセンター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：BioHorizons、Atrium Medical、Smith & Nephew、Biomet、LifeCell、Geistlich、Cook Medical、MiMedx、RTI Biologics、Zimmer Holdings、Boston Scientific、Dentsply、American Medical Systems、Ethicon、Medtronic、Integra LifeSciences and Citagenix、Stryker ・地域別グローバル市場分析 2015年-2020年 ・軟部肉腫治療の北米市場（アメリカ、カナダ、メキシコ） ・軟部肉腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・軟部肉腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・軟部肉腫治療の南米市場（ブラジル、アルゼンチン） ・軟部肉腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学治療、標的治療、抗血管新生薬、放射線治療 ・用途別分析：病院、腫瘍学センター、長期ケアセンター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Soft Tissue Sarcoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Soft Tissue Sarcoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Soft Tissue Sarcoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Soft Tissue Sarcoma Treatment market has been segmented into:
Chemotherapy
Targeted Therapy
Anti-angiogenesis drugs
Radiation Therapy
By Application, Soft Tissue Sarcoma Treatment has been segmented into:
Hospitals
Oncology Centers
Long Term Care Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Soft Tissue Sarcoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Soft Tissue Sarcoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Soft Tissue Sarcoma Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Soft Tissue Sarcoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Soft Tissue Sarcoma Treatment Market Share Analysis
Soft Tissue Sarcoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Soft Tissue Sarcoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Soft Tissue Sarcoma Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Soft Tissue Sarcoma Treatment are:
BioHorizons
Atrium Medical
Smith & Nephew
Biomet
LifeCell
Geistlich
Cook Medical
MiMedx
RTI Biologics
Zimmer Holdings
Boston Scientific
Dentsply
American Medical Systems
Ethicon
Medtronic
Integra LifeSciences and Citagenix
Stryker
Table of Contents
1 Soft Tissue Sarcoma Treatment Market Overview
1.1 Product Overview and Scope of Soft Tissue Sarcoma Treatment
1.2 Classification of Soft Tissue Sarcoma Treatment by Type
1.2.1 Global Soft Tissue Sarcoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Soft Tissue Sarcoma Treatment Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Targeted Therapy
1.2.5 Anti-angiogenesis drugs
1.2.6 Radiation Therapy
1.3 Global Soft Tissue Sarcoma Treatment Market by Application
1.3.1 Overview: Global Soft Tissue Sarcoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Oncology Centers
1.3.4 Long Term Care Centers
1.4 Global Soft Tissue Sarcoma Treatment Market by Regions
1.4.1 Global Soft Tissue Sarcoma Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Soft Tissue Sarcoma Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Soft Tissue Sarcoma Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Soft Tissue Sarcoma Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Soft Tissue Sarcoma Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Soft Tissue Sarcoma Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Soft Tissue Sarcoma Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 BioHorizons
2.1.1 BioHorizons Details
2.1.2 BioHorizons Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BioHorizons SWOT Analysis
2.1.4 BioHorizons Product and Services
2.1.5 BioHorizons Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Atrium Medical
2.2.1 Atrium Medical Details
2.2.2 Atrium Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Atrium Medical SWOT Analysis
2.2.4 Atrium Medical Product and Services
2.2.5 Atrium Medical Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Smith & Nephew
2.3.1 Smith & Nephew Details
2.3.2 Smith & Nephew Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Smith & Nephew SWOT Analysis
2.3.4 Smith & Nephew Product and Services
2.3.5 Smith & Nephew Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biomet
2.4.1 Biomet Details
2.4.2 Biomet Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biomet SWOT Analysis
2.4.4 Biomet Product and Services
2.4.5 Biomet Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 LifeCell
2.5.1 LifeCell Details
2.5.2 LifeCell Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LifeCell SWOT Analysis
2.5.4 LifeCell Product and Services
2.5.5 LifeCell Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Geistlich
2.6.1 Geistlich Details
2.6.2 Geistlich Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Geistlich SWOT Analysis
2.6.4 Geistlich Product and Services
2.6.5 Geistlich Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cook Medical
2.7.1 Cook Medical Details
2.7.2 Cook Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cook Medical SWOT Analysis
2.7.4 Cook Medical Product and Services
2.7.5 Cook Medical Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 MiMedx
2.8.1 MiMedx Details
2.8.2 MiMedx Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MiMedx SWOT Analysis
2.8.4 MiMedx Product and Services
2.8.5 MiMedx Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 RTI Biologics
2.9.1 RTI Biologics Details
2.9.2 RTI Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 RTI Biologics SWOT Analysis
2.9.4 RTI Biologics Product and Services
2.9.5 RTI Biologics Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Zimmer Holdings
2.10.1 Zimmer Holdings Details
2.10.2 Zimmer Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Zimmer Holdings SWOT Analysis
2.10.4 Zimmer Holdings Product and Services
2.10.5 Zimmer Holdings Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Boston Scientific
2.11.1 Boston Scientific Details
2.11.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Boston Scientific SWOT Analysis
2.11.4 Boston Scientific Product and Services
2.11.5 Boston Scientific Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Dentsply
2.12.1 Dentsply Details
2.12.2 Dentsply Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Dentsply SWOT Analysis
2.12.4 Dentsply Product and Services
2.12.5 Dentsply Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 American Medical Systems
2.13.1 American Medical Systems Details
2.13.2 American Medical Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 American Medical Systems SWOT Analysis
2.13.4 American Medical Systems Product and Services
2.13.5 American Medical Systems Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Ethicon
2.14.1 Ethicon Details
2.14.2 Ethicon Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Ethicon SWOT Analysis
2.14.4 Ethicon Product and Services
2.14.5 Ethicon Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Medtronic
2.15.1 Medtronic Details
2.15.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Medtronic SWOT Analysis
2.15.4 Medtronic Product and Services
2.15.5 Medtronic Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Integra LifeSciences and Citagenix
2.16.1 Integra LifeSciences and Citagenix Details
2.16.2 Integra LifeSciences and Citagenix Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Integra LifeSciences and Citagenix SWOT Analysis
2.16.4 Integra LifeSciences and Citagenix Product and Services
2.16.5 Integra LifeSciences and Citagenix Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Stryker
2.17.1 Stryker Details
2.17.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Stryker SWOT Analysis
2.17.4 Stryker Product and Services
2.17.5 Stryker Soft Tissue Sarcoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Soft Tissue Sarcoma Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Soft Tissue Sarcoma Treatment Players Market Share
3.2.2 Top 10 Soft Tissue Sarcoma Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Soft Tissue Sarcoma Treatment Revenue and Market Share by Regions
4.2 North America Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
5 North America Soft Tissue Sarcoma Treatment Revenue by Countries
5.1 North America Soft Tissue Sarcoma Treatment Revenue by Countries (2015-2020)
5.2 USA Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
6 Europe Soft Tissue Sarcoma Treatment Revenue by Countries
6.1 Europe Soft Tissue Sarcoma Treatment Revenue by Countries (2015-2020)
6.2 Germany Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
6.4 France Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Soft Tissue Sarcoma Treatment Revenue by Countries
7.1 Asia-Pacific Soft Tissue Sarcoma Treatment Revenue by Countries (2015-2020)
7.2 China Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
7.5 India Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
8 South America Soft Tissue Sarcoma Treatment Revenue by Countries
8.1 South America Soft Tissue Sarcoma Treatment Revenue by Countries (2015-2020)
8.2 Brazil Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Soft Tissue Sarcoma Treatment by Countries
9.1 Middle East & Africa Soft Tissue Sarcoma Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Soft Tissue Sarcoma Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Soft Tissue Sarcoma Treatment Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Targeted Therapy Revenue Growth Rate (2015-2025)
10.5 Anti-angiogenesis drugs Revenue Growth Rate (2015-2025)
10.6 Radiation Therapy Revenue Growth Rate (2015-2025)
11 Global Soft Tissue Sarcoma Treatment Market Segment by Application
11.1 Global Soft Tissue Sarcoma Treatment Revenue Market Share by Application (2015-2020)
11.2 Soft Tissue Sarcoma Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Oncology Centers Revenue Growth (2015-2020)
11.5 Long Term Care Centers Revenue Growth (2015-2020)
12 Global Soft Tissue Sarcoma Treatment Market Size Forecast (2021-2025)
12.1 Global Soft Tissue Sarcoma Treatment Market Size Forecast (2021-2025)
12.2 Global Soft Tissue Sarcoma Treatment Market Forecast by Regions (2021-2025)
12.3 North America Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
12.6 South America Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Soft Tissue Sarcoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Soft Tissue Sarcoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Soft Tissue Sarcoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Soft Tissue Sarcoma Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. BioHorizons Corporate Information, Location and Competitors
Table 6. BioHorizons Soft Tissue Sarcoma Treatment Major Business
Table 7. BioHorizons Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 8. BioHorizons SWOT Analysis
Table 9. BioHorizons Soft Tissue Sarcoma Treatment Product and Solutions
Table 10. BioHorizons Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Atrium Medical Corporate Information, Location and Competitors
Table 12. Atrium Medical Soft Tissue Sarcoma Treatment Major Business
Table 13. Atrium Medical Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Atrium Medical SWOT Analysis
Table 15. Atrium Medical Soft Tissue Sarcoma Treatment Product and Solutions
Table 16. Atrium Medical Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Smith & Nephew Corporate Information, Location and Competitors
Table 18. Smith & Nephew Soft Tissue Sarcoma Treatment Major Business
Table 19. Smith & Nephew Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Smith & Nephew SWOT Analysis
Table 21. Smith & Nephew Soft Tissue Sarcoma Treatment Product and Solutions
Table 22. Smith & Nephew Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Biomet Corporate Information, Location and Competitors
Table 24. Biomet Soft Tissue Sarcoma Treatment Major Business
Table 25. Biomet Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Biomet SWOT Analysis
Table 27. Biomet Soft Tissue Sarcoma Treatment Product and Solutions
Table 28. Biomet Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. LifeCell Corporate Information, Location and Competitors
Table 30. LifeCell Soft Tissue Sarcoma Treatment Major Business
Table 31. LifeCell Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 32. LifeCell SWOT Analysis
Table 33. LifeCell Soft Tissue Sarcoma Treatment Product and Solutions
Table 34. LifeCell Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Geistlich Corporate Information, Location and Competitors
Table 36. Geistlich Soft Tissue Sarcoma Treatment Major Business
Table 37. Geistlich Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Geistlich SWOT Analysis
Table 39. Geistlich Soft Tissue Sarcoma Treatment Product and Solutions
Table 40. Geistlich Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cook Medical Corporate Information, Location and Competitors
Table 42. Cook Medical Soft Tissue Sarcoma Treatment Major Business
Table 43. Cook Medical Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Cook Medical SWOT Analysis
Table 45. Cook Medical Soft Tissue Sarcoma Treatment Product and Solutions
Table 46. Cook Medical Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. MiMedx Corporate Information, Location and Competitors
Table 48. MiMedx Soft Tissue Sarcoma Treatment Major Business
Table 49. MiMedx Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 50. MiMedx SWOT Analysis
Table 51. MiMedx Soft Tissue Sarcoma Treatment Product and Solutions
Table 52. MiMedx Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. RTI Biologics Corporate Information, Location and Competitors
Table 54. RTI Biologics Soft Tissue Sarcoma Treatment Major Business
Table 55. RTI Biologics Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 56. RTI Biologics SWOT Analysis
Table 57. RTI Biologics Soft Tissue Sarcoma Treatment Product and Solutions
Table 58. RTI Biologics Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Zimmer Holdings Corporate Information, Location and Competitors
Table 60. Zimmer Holdings Soft Tissue Sarcoma Treatment Major Business
Table 61. Zimmer Holdings Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Zimmer Holdings SWOT Analysis
Table 63. Zimmer Holdings Soft Tissue Sarcoma Treatment Product and Solutions
Table 64. Zimmer Holdings Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Boston Scientific Corporate Information, Location and Competitors
Table 66. Boston Scientific Soft Tissue Sarcoma Treatment Major Business
Table 67. Boston Scientific Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Boston Scientific SWOT Analysis
Table 69. Boston Scientific Soft Tissue Sarcoma Treatment Product and Solutions
Table 70. Boston Scientific Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Dentsply Corporate Information, Location and Competitors
Table 72. Dentsply Soft Tissue Sarcoma Treatment Major Business
Table 73. Dentsply Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Dentsply SWOT Analysis
Table 75. Dentsply Soft Tissue Sarcoma Treatment Product and Solutions
Table 76. Dentsply Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. American Medical Systems Corporate Information, Location and Competitors
Table 78. American Medical Systems Soft Tissue Sarcoma Treatment Major Business
Table 79. American Medical Systems Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 80. American Medical Systems SWOT Analysis
Table 81. American Medical Systems Soft Tissue Sarcoma Treatment Product and Solutions
Table 82. American Medical Systems Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Ethicon Corporate Information, Location and Competitors
Table 84. Ethicon Soft Tissue Sarcoma Treatment Major Business
Table 85. Ethicon Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Ethicon SWOT Analysis
Table 87. Ethicon Soft Tissue Sarcoma Treatment Product and Solutions
Table 88. Ethicon Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Medtronic Corporate Information, Location and Competitors
Table 90. Medtronic Soft Tissue Sarcoma Treatment Major Business
Table 91. Medtronic Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Medtronic SWOT Analysis
Table 93. Medtronic Soft Tissue Sarcoma Treatment Product and Solutions
Table 94. Medtronic Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Integra LifeSciences and Citagenix Corporate Information, Location and Competitors
Table 96. Integra LifeSciences and Citagenix Soft Tissue Sarcoma Treatment Major Business
Table 97. Integra LifeSciences and Citagenix Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 98. Integra LifeSciences and Citagenix SWOT Analysis
Table 99. Integra LifeSciences and Citagenix Soft Tissue Sarcoma Treatment Product and Solutions
Table 100. Integra LifeSciences and Citagenix Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Stryker Corporate Information, Location and Competitors
Table 102. Stryker Soft Tissue Sarcoma Treatment Major Business
Table 103. Stryker Soft Tissue Sarcoma Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Stryker SWOT Analysis
Table 105. Stryker Soft Tissue Sarcoma Treatment Product and Solutions
Table 106. Stryker Soft Tissue Sarcoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) by Players (2015-2020)
Table 108. Global Soft Tissue Sarcoma Treatment Revenue Share by Players (2015-2020)
Table 109. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Soft Tissue Sarcoma Treatment Revenue Market Share by Regions (2015-2020)
Table 111. North America Soft Tissue Sarcoma Treatment Revenue by Countries (2015-2020)
Table 112. North America Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Table 113. Europe Soft Tissue Sarcoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Soft Tissue Sarcoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Soft Tissue Sarcoma Treatment Revenue by Countries (2015-2020)
Table 116. South America Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Soft Tissue Sarcoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Table 119. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) by Type (2015-2020)
Table 120. Global Soft Tissue Sarcoma Treatment Revenue Share by Type (2015-2020)
Table 121. Global Soft Tissue Sarcoma Treatment Revenue Forecast by Type (2021-2025)
Table 122. Global Soft Tissue Sarcoma Treatment Revenue by Application (2015-2020)
Table 123. Global Soft Tissue Sarcoma Treatment Revenue Share by Application (2015-2020)
Table 124. Global Soft Tissue Sarcoma Treatment Revenue Forecast by Application (2021-2025)
Table 125. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Soft Tissue Sarcoma Treatment Picture
Figure 2. Global Soft Tissue Sarcoma Treatment Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Targeted Therapy Picture
Figure 5. Anti-angiogenesis drugs Picture
Figure 6. Radiation Therapy Picture
Figure 7. Soft Tissue Sarcoma Treatment Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Oncology Centers Picture
Figure 10. Long Term Care Centers Picture
Figure 11. Global Soft Tissue Sarcoma Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Soft Tissue Sarcoma Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Soft Tissue Sarcoma Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Soft Tissue Sarcoma Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Soft Tissue Sarcoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Soft Tissue Sarcoma Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Soft Tissue Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Soft Tissue Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Soft Tissue Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 44. China Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Soft Tissue Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Soft Tissue Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Soft Tissue Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Soft Tissue Sarcoma Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Soft Tissue Sarcoma Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Soft Tissue Sarcoma Treatment Revenue Share by Type in 2019
Figure 61. Global Soft Tissue Sarcoma Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Anti-angiogenesis drugs Revenue Growth Rate (2015-2020)
Figure 65. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Soft Tissue Sarcoma Treatment Revenue Share by Application (2015-2020)
Figure 67. Global Soft Tissue Sarcoma Treatment Revenue Share by Application in 2019
Figure 68. Global Soft Tissue Sarcoma Treatment Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Oncology Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Long Term Care Centers Revenue Growth Rate (2015-2020)
Figure 72. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Soft Tissue Sarcoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Soft Tissue Sarcoma Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Soft Tissue Sarcoma Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
軟部組織強化・再生の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Soft Tissue Reinforcement and Regeneration market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The So…- 軟部組織同種移植片の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Soft Tissue Allografts market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 3498.8 million by 2025, from USD 2881.1 million in 2019. The Soft Tissue A…
- カポジ肉腫の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Kaposi Sarcoma market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.7% in the forecast period of 2020 to 2025 and will expected to reach USD 115.7 million by 2025, from USD 108 million in 2019. The Kaposi Sarcoma market rep…
- 結合組織成長因子の世界市場レポート2020 Market Analysis and Insights: Global Connective Tissue Growth Factor Market The global Connective Tissue Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Connective Tissue Growth Factor Scope…
- 創傷組織分析ソリューションの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Wound Tissue Analysis Solutions market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wound Tissue …